
From the Editor: A year in turmoil
For the drug discovery, and wider pharmaceutical industry, the year of 2025 can be characterised by the words turmoil and uncertainty. The second coming of President Trump brought with it a flurry of executive orders, tariffs and global bargaining that placed the US in a position… Read More















